Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression (Q28275200)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression |
scientific article |
Statements
Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression (English)
0 references
15 November 2006
0 references
12
0 references
22
0 references
6637-42
0 references
1 reference